Literature DB >> 18469545

Comparative analysis of homocysteine concentrations in patients with retinal vein occlusion versus thrombotic and atherosclerotic disorders.

Anat Kesler1, Varda Shalev, Ori Rogowski, Orit Shimron, Bracha Shainberg, Ben-Ami Sela, Itzhak Shapira, Ophira Salomon, Shlomo Berliner.   

Abstract

The objectives of the present study were to determine the concentrations of plasma homocysteine in a large (n = 562) cohort of patients with retinal vein occlusion (RVO) and to compare them with the values observed in other vascular thrombotic and atherosclerotic conditions. Results were compared with those observed in patients with deep vein thrombosis (n = 1700), pulmonary embolism (n = 542), transient ischemic attack (n = 1301), cerebrovascular accident (n = 1299), myocardial infarction (n = 3087), as well as peripheral artery occlusive disease (n = 1946). No differences were found between the age-adjusted estimated marginal mean +/- SE for homocysteine concentrations in individuals with RVO and in those who had other atherosclerotic and atherothrombotic diseases The respective concentrations for RVO, deep vein thrombosis, pulmonary embolism, transient ischemic attack, cerebrovascular accident, myocardial infarction, and peripheral artery occlusive disease were 13.8 +/- 0.4, 14.7 +/- 0.3, 14.3 +/- 0.5, 14.2 +/- 0.3,14.6 +/- 0.3, 13.8 +/- 0.2, 14.4 +/- 0.2 pmol/l for men and 11.4 +/- 0.4, 10.7 +/- 0.2, 10.8 +/- 0.3, 10.8 +/- 0.2, 11.8 +/- 0.2, 11.2 +/- 0.2 pmol/l for women. In conclusion, the concentrations of homocysteine observed in patients with RVO are similar to those detected in other thrombotic and atherosclerotic vascular disorders. In view of the fact that this is a common disorder of the elderly, increased homocysteine concentrations often reported in patients with RVO could reflect the underlying atherothrombotic condition and might not necessarily be specifically related to the RVO per se. This information is relevant in researching the potential etiopathologic role, if any, of increased homocysteine concentrations in RVO.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469545     DOI: 10.1097/MBC.0b013e3282f2b60e

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  4 in total

1.  Inflammation in retinal vein occlusion.

Authors:  Avnish Deobhakta; Louis K Chang
Journal:  Int J Inflam       Date:  2013-04-03

2.  Elevated Monocyte-to-High-Density Lipoprotein Ratio as an Indicator of Systemic Inflammation in Patients with Branch Retinal Vein Occlusion.

Authors:  Zeynep Duru; Orhan Altunel; Bedirhan Alabay; Ender Sirakaya; Ender Sirakaya; Bekir Kucuk; Musa Musaoglu
Journal:  Beyoglu Eye J       Date:  2021-09-24

3.  Hyperhomocysteinia is a risk factor for retinal venous occlusion: a case control study.

Authors:  Fahad Al Wadani; Rajiv Khandekar; Gigani Salim; Mohammed Al Ali; Salman Ramzi
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

4.  Association between retinal vein occlusion and an increased risk of acute myocardial infarction: A nationwide population-based follow-up study.

Authors:  Yu-Yen Chen; Shwu-Jiuan Sheu; Hsiao-Yun Hu; Dachen Chu; Pesus Chou
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.